WO2008055801A3 - Anti-diabetogene calcium-peptid-zusammensetzung - Google Patents

Anti-diabetogene calcium-peptid-zusammensetzung Download PDF

Info

Publication number
WO2008055801A3
WO2008055801A3 PCT/EP2007/061611 EP2007061611W WO2008055801A3 WO 2008055801 A3 WO2008055801 A3 WO 2008055801A3 EP 2007061611 W EP2007061611 W EP 2007061611W WO 2008055801 A3 WO2008055801 A3 WO 2008055801A3
Authority
WO
WIPO (PCT)
Prior art keywords
calcium
antidiabetogenic
peptide composition
diabetes
type
Prior art date
Application number
PCT/EP2007/061611
Other languages
English (en)
French (fr)
Other versions
WO2008055801A2 (de
Inventor
Marco Sell
Dirk Bode
Guenther Sawatzki
Original Assignee
Humana Milchunion Eg
Marco Sell
Dirk Bode
Guenther Sawatzki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Humana Milchunion Eg, Marco Sell, Dirk Bode, Guenther Sawatzki filed Critical Humana Milchunion Eg
Priority to EA200970441A priority Critical patent/EA016545B1/ru
Priority to EP07847082A priority patent/EP2089046A2/de
Publication of WO2008055801A2 publication Critical patent/WO2008055801A2/de
Publication of WO2008055801A3 publication Critical patent/WO2008055801A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Die vorliegende Erfindung betrifft die Verwendung einer Calcium-Peptid-Zusammensetzung erhältlich aus - mindestens einem Calciumsalz, - mindestens einem Caseinophosphopeptid (CPP) und/oder - mindestens einem Glycomakropeptid (GMP) zur Herstellung eines Mittels zur Prävention und/oder zur Behandlung von Diabetes (Typ II). Durch die Darreichung dieser Zusammensetzung ist es möglich, die Entstehung des Diabetes (Typ II) deutlich zu unterdrücken (anti-diabetogene Wirkung).
PCT/EP2007/061611 2006-11-06 2007-10-29 Anti-diabetogene calcium-peptid-zusammensetzung WO2008055801A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EA200970441A EA016545B1 (ru) 2006-11-06 2007-10-29 Применение кальций-пептидной композиции для профилактики и/или лечения сахарного диабета ii типа
EP07847082A EP2089046A2 (de) 2006-11-06 2007-10-29 Anti-diabetogene calcium-peptid-zusammensetzung

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006052560.4 2006-11-06
DE102006052560A DE102006052560B4 (de) 2006-11-06 2006-11-06 Anti-diabetogene Calcium-Peptid-Zusammensetzung

Publications (2)

Publication Number Publication Date
WO2008055801A2 WO2008055801A2 (de) 2008-05-15
WO2008055801A3 true WO2008055801A3 (de) 2008-12-04

Family

ID=39148568

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/061611 WO2008055801A2 (de) 2006-11-06 2007-10-29 Anti-diabetogene calcium-peptid-zusammensetzung

Country Status (5)

Country Link
EP (1) EP2089046A2 (de)
DE (1) DE102006052560B4 (de)
EA (1) EA016545B1 (de)
UA (1) UA95497C2 (de)
WO (1) WO2008055801A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2413952B2 (de) 2009-04-03 2019-10-02 Société des Produits Nestlé S.A. Verbesserung bei der Förderung von gesundem Aufholwachstum
CN109846901A (zh) * 2019-04-03 2019-06-07 江西安顺堂生物科技有限公司 一种促进骨骼生长、防龋齿、补充钙的制剂及制备工艺

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442132A (en) * 1978-11-13 1984-04-10 C.V. Chemie Combinatie Amsterdam C.C.A. Light bakery products for diabetics and method for the preparation of these products
WO2002017734A2 (en) * 2000-09-01 2002-03-07 The University Of Tennessee Research Corporation Materials and methods for the treatment or prevention of obesity
WO2002052954A2 (en) * 2001-01-08 2002-07-11 Societe Des Produits Nestle S.A. Nutritional composition for a bone condition
US20030008810A1 (en) * 2000-02-23 2003-01-09 Robert Portman Nutritional intervention composition for enhancing and extending satiety
CN1395870A (zh) * 2002-07-25 2003-02-12 徐佳立 多肽降糖保健食品
WO2004112766A1 (en) * 2003-06-25 2004-12-29 Hyundeok Bio & Technology Co., Ltd. Composition for lowering blood glucose
WO2007009529A2 (de) * 2005-07-19 2007-01-25 Humana Gmbh Calcium-peptid-komponente

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9927603D0 (en) * 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
US20030165574A1 (en) * 2002-03-01 2003-09-04 Ward Loren Spencer Compositions and methods for treatment of body weight conditions

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442132A (en) * 1978-11-13 1984-04-10 C.V. Chemie Combinatie Amsterdam C.C.A. Light bakery products for diabetics and method for the preparation of these products
US20030008810A1 (en) * 2000-02-23 2003-01-09 Robert Portman Nutritional intervention composition for enhancing and extending satiety
WO2002017734A2 (en) * 2000-09-01 2002-03-07 The University Of Tennessee Research Corporation Materials and methods for the treatment or prevention of obesity
WO2002052954A2 (en) * 2001-01-08 2002-07-11 Societe Des Produits Nestle S.A. Nutritional composition for a bone condition
CN1395870A (zh) * 2002-07-25 2003-02-12 徐佳立 多肽降糖保健食品
WO2004112766A1 (en) * 2003-06-25 2004-12-29 Hyundeok Bio & Technology Co., Ltd. Composition for lowering blood glucose
WO2007009529A2 (de) * 2005-07-19 2007-01-25 Humana Gmbh Calcium-peptid-komponente

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200320, 2 December 2003 Derwent World Patents Index; Class 033, Page 6, AN 2003-373067, XP002499190, XU J: "Hypoglycemic health-care polypeptide food" *
ETZEL M R: "Manufacture and Use of Dairy Protein Fractions", JOURNAL OF NUTRITION 200404 US, vol. 134, no. 4, April 2004 (2004-04-01), pages 996S - 1002S, XP002499258, ISSN: 0022-3166 *
VISSER JEROEN ET AL: "Short-term dietary adjustment with a hydrolyzed casein-based diet postpones diabetes development in the diabetes-prone BB rat.", METABOLISM CLINICAL AND EXPERIMENTAL, vol. 52, no. 3, March 2003 (2003-03-01), pages 333 - 337, XP008097437, ISSN: 0026-0495 *

Also Published As

Publication number Publication date
EP2089046A2 (de) 2009-08-19
EA016545B1 (ru) 2012-05-30
DE102006052560B4 (de) 2010-01-21
EA200970441A1 (ru) 2009-12-30
DE102006052560A1 (de) 2008-05-08
UA95497C2 (ru) 2011-08-10
WO2008055801A2 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
WO2008097640A3 (en) Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
WO2007139967A3 (en) Triazole compounds that modulate hsp90 activity
WO2007139955A3 (en) Triazole compounds that modulate hsp90 activity
WO2007139968A3 (en) Triazole compounds that modulate hsp90 activity
WO2007094819A3 (en) Triazole compounds that modulate hsp90 activity
WO2009026179A3 (en) Antiinfective proanthocyanidin compounds and methods of use thereof
WO2007052023A3 (en) Novel compounds
WO2007016538A3 (en) Preparation and use of biphenyl amino acid derivatives for the treatment of obesity
WO2010017545A3 (en) Triazole compounds that modulate hsp90 activity
TW200745003A (en) Novel compounds
WO2009129246A3 (en) Compositions and methods for preparing and using same
TW200732296A (en) Novel compounds
WO2006102610A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2007150015A3 (en) Method of treatment
TW200612892A (en) Novel compounds
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
WO2008048589A3 (en) Compounds and methods for treatment of hcv
MY150702A (en) Substituted 4-phenyltetrahydroisoquinonelines, method of producing them, their use as medicament, and also medicament containing them
WO2007109279A3 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
WO2006128041A3 (en) Compositions and methods for the treatment or prevention of chemoresistant neoplasia
TW200731974A (en) Transdermal system for verenicline
CL2007003722A1 (es) Compuestos derivados de propionamida n-sustituida por heterociclo, activadores de glucoquinasa; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento o prevencion de la diabetes.
WO2007028022A3 (en) Novel compounds as p2x7 modulators and uses thereof
WO2006114439A3 (en) Novel nutraceutical compositions
PL2083809T3 (pl) Kompozycja dietetyczna lub farmaceutyczna zawierająca tricykliczne diterpeny do leczenia depresji

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07847082

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 200970441

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 2007847082

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: a200905665

Country of ref document: UA